Search alternatives:
treatment decreased » treatment increases (Expand Search)
marker decrease » marked decrease (Expand Search), larger decrease (Expand Search), marked increase (Expand Search)
a treatment » _ treatment (Expand Search), 1 treatment (Expand Search), day treatment (Expand Search)
a marker » _ marker (Expand Search), _ markers (Expand Search)
c large » _ large (Expand Search), a large (Expand Search), b large (Expand Search)
i large » _ large (Expand Search), a large (Expand Search), via large (Expand Search)
treatment decreased » treatment increases (Expand Search)
marker decrease » marked decrease (Expand Search), larger decrease (Expand Search), marked increase (Expand Search)
a treatment » _ treatment (Expand Search), 1 treatment (Expand Search), day treatment (Expand Search)
a marker » _ marker (Expand Search), _ markers (Expand Search)
c large » _ large (Expand Search), a large (Expand Search), b large (Expand Search)
i large » _ large (Expand Search), a large (Expand Search), via large (Expand Search)
-
1
-
2
-
3
-
4
FTY720 treatment decreased tumor growth in a xenograft model of hepatoblastoma.
Published 2019“…The mean ± SEM for each treatment group were calculated and depicted in a bar graph. …”
-
5
-
6
-
7
-
8
-
9
-
10
-
11
Both cis- and trans-cycles decrease in number upon treatment with auxin.
Published 2023“…<p>(A) and (B) The number of cis-cycles decreased upon the addition of auxin, irrespective of cycle length and the maximal bin distance between contiguous bins. …”
-
12
-
13
-
14
-
15
-
16
Prestroke Glucose Control and Functional Outcome in Patients With Acute Large Vessel Occlusive Stroke and Diabetes After Thrombectomy
Published 2021“…The association was consistently observed in subgroups divided according to age, sex, stroke subtype, occlusion site, degree of recanalization, thrombolysis modalities, time from symptom onset to groin puncture, and treatment period. </p> <p>CONCLUSIONS</p> <p>Prestroke glucose control with a target HbA1c of ≤ 7.0 may be beneficial for neurological recovery in patients with diabetes undergoing IAT for large vessel occlusive stroke, regardless of stroke subtype, bridging intravenous thrombolysis, occlusion site, degree of recanalization, and treatment period. …”
-
17
-
18
-
19
-
20